Patients, Doctors Await FDA Decision on Experimental Alzheimer’s Drug 0 06.01.2023 00:00 MtStandard.com THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer’s disease. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
